Literature DB >> 22232295

Methadone as social control: institutionalized stigma and the prospect of recovery.

Julie Harris1, Karen McElrath.   

Abstract

Methadone maintenance treatment (MMT) is an intervention used to treat opioid (heroin) dependence. Several investigators have found that MMT is effective in reducing heroin use and other behaviors; however, a disproportionate number of MMT clients leave treatment prematurely. Moreover, MMT outcome variables are often limited in terms of their measurement. Utilizing an integrated theoretical framework of social control and stigma, we focused on the experiences of methadone maintenance from the perspective of clients. We pooled interview data from four qualitative studies in two jurisdictions and found linkages between social control and institutional stigma that serve to reinforce "addict" identities, expose undeserving customers to the public gaze, and encourage clients to be passive recipients of treatment. We discuss the implications for recovery and suggest recommendations for change.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22232295     DOI: 10.1177/1049732311432718

Source DB:  PubMed          Journal:  Qual Health Res        ISSN: 1049-7323


  32 in total

1.  Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study.

Authors:  Ryan McNeil; Thomas Kerr; Solanna Anderson; Lisa Maher; Chereece Keewatin; M J Milloy; Evan Wood; Will Small
Journal:  Soc Sci Med       Date:  2015-04-07       Impact factor: 4.634

2.  Emergency Department Initiation of Buprenorphine for Opioid Use Disorder: Current Status, and Future Potential.

Authors:  Lindsay Fox; Lewis S Nelson
Journal:  CNS Drugs       Date:  2019-12       Impact factor: 5.749

3.  Social and Structural Challenges to Drug Cessation Among Couples in Northern Mexico: Implications for Drug Treatment in Underserved Communities.

Authors:  Angela R Bazzi; Jennifer L Syvertsen; María Luisa Rolón; Gustavo Martinez; Gudelia Rangel; Alicia Vera; Hortensia Amaro; Monica D Ulibarri; Daniel O Hernandez; Steffanie A Strathdee
Journal:  J Subst Abuse Treat       Date:  2015-09-21

4.  Struggling to achieve a 'normal life': A qualitative study of Vietnamese methadone patients.

Authors:  Thu Trang Nguyen; Anh Ngoc Luong; Thi Tuyet Thanh Nham; Carole Chauvin; Jonathan Feelemyer; Nicolas Nagot; Don Des Jarlais; Minh Giang Le; Marie Jauffret-Roustide
Journal:  Int J Drug Policy       Date:  2019-04-09

5.  Shifting blame: Buprenorphine prescribers, addiction treatment, and prescription monitoring in middle-class America.

Authors:  Sonia Mendoza; Allyssa S Rivera-Cabrero; Helena Hansen
Journal:  Transcult Psychiatry       Date:  2016-08-03

6.  Applying principles of injury and infectious disease control to the opioid mortality epidemic in North America: critical intervention gaps.

Authors:  Benedikt Fischer; Michelle Pang; Mark Tyndall
Journal:  J Public Health (Oxf)       Date:  2020-11-23       Impact factor: 2.341

7.  'Crisis' and 'everyday' initiators: A qualitative study of coercion and agency in the context of methadone maintenance treatment initiation.

Authors:  Will Damon; Will Small; Solanna Anderson; Lisa Maher; Evan Wood; Thomas Kerr; Ryan McNeil
Journal:  Drug Alcohol Rev       Date:  2016-04-29

8.  Impact of research network participation on the adoption of buprenorphine for substance abuse treatment.

Authors:  Traci R Rieckmann; Amanda J Abraham; Anne E Kovas; Bentson H McFarland; Paul M Roman
Journal:  Addict Behav       Date:  2014-02-07       Impact factor: 3.913

9.  "How will I get my next week's script?" Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic.

Authors:  Noa Krawczyk; Amanda M Bunting; David Frank; Joshua Arshonsky; Yuanqi Gu; Samuel R Friedman; Marie A Bragg
Journal:  Int J Drug Policy       Date:  2021-02-06

10.  A qualitative investigation of addiction counselors' perceptions and experiences implementing an open-access model for treating opioid use disorder.

Authors:  Lindsay M S Oberleitner; Lynn M Madden; Dharushana Muthulingam; Ruthanne Marcus; David E Oberleitner; Mark Beitel; Marina Gaeta; Joseph F Tamberelli; Declan T Barry
Journal:  J Subst Abuse Treat       Date:  2020-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.